MORRELL'S PHARMACY LIMITED

Company Registration Number:
04714818 (England and Wales)

Unaudited abridged accounts for the year ended 30 September 2024

Period of accounts

Start date: 01 October 2023

End date: 30 September 2024

MORRELL'S PHARMACY LIMITED

Contents of the Financial Statements

for the Period Ended 30 September 2024

Balance sheet
Notes

MORRELL'S PHARMACY LIMITED

Balance sheet

As at 30 September 2024


Notes

2024

2023


£

£
Fixed assets
Intangible assets: 3 51,269 56,572
Tangible assets: 4 32,938 35,060
Total fixed assets: 84,207 91,632
Current assets
Stocks: 42,257 48,297
Debtors: 5 1,152,296 1,100,781
Cash at bank and in hand: 209,800 271,893
Total current assets: 1,404,353 1,420,971
Creditors: amounts falling due within one year: 6 (191,399) (214,298)
Net current assets (liabilities): 1,212,954 1,206,673
Total assets less current liabilities: 1,297,161 1,298,305
Total net assets (liabilities): 1,297,161 1,298,305
Capital and reserves
Called up share capital: 100 100
Profit and loss account: 1,297,061 1,298,205
Shareholders funds: 1,297,161 1,298,305

The notes form part of these financial statements

MORRELL'S PHARMACY LIMITED

Balance sheet statements

For the year ending 30 September 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 25 June 2025
and signed on behalf of the board by:

Name: Michael Morrell
Status: Director

The notes form part of these financial statements

MORRELL'S PHARMACY LIMITED

Notes to the Financial Statements

for the Period Ended 30 September 2024

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

Turnover policy

Turnover represents net invoiced sales of goods and services, excluding value added tax

Tangible fixed assets and depreciation policy

Property, plant and equipment, other than freehold land are stated at cost or valuation less depreciation and any provision impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis: Leasehold Property - 2.5% on reducing balance Office Equipment - 15% on reducing balance Ford Fiesta Van - 15% on reducing balance Fixtures and Fittings - 15% on reducing balance

Intangible fixed assets and amortisation policy

The Lease Premium is being amortised over the term of the lease which is 25 years less 3 days. The annual charge is £5,302.72.

Valuation and information policy

Inventories are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

MORRELL'S PHARMACY LIMITED

Notes to the Financial Statements

for the Period Ended 30 September 2024

2. Employees

2024 2023
Average number of employees during the period 12 10

MORRELL'S PHARMACY LIMITED

Notes to the Financial Statements

for the Period Ended 30 September 2024

3. Intangible Assets

Total
Cost £
At 01 October 2023 132,568
At 30 September 2024 132,568
Amortisation
At 01 October 2023 75,996
Charge for year 5,303
At 30 September 2024 81,299
Net book value
At 30 September 2024 51,269
At 30 September 2023 56,572

MORRELL'S PHARMACY LIMITED

Notes to the Financial Statements

for the Period Ended 30 September 2024

4. Tangible Assets

Total
Cost £
At 01 October 2023 119,864
At 30 September 2024 119,864
Depreciation
At 01 October 2023 84,804
Charge for year 2,122
At 30 September 2024 86,926
Net book value
At 30 September 2024 32,938
At 30 September 2023 35,060

MORRELL'S PHARMACY LIMITED

Notes to the Financial Statements

for the Period Ended 30 September 2024

5. Debtors

2024 2023
££
Debtors due after more than one year: 0 0

MORRELL'S PHARMACY LIMITED

Notes to the Financial Statements

for the Period Ended 30 September 2024

6. Creditors: amounts falling due within one year note

Trade Creditors £135,171 Other Creditors £26,485 Corporation Tax £27099 Taxation and Social Security £2,644

MORRELL'S PHARMACY LIMITED

Notes to the Financial Statements

for the Period Ended 30 September 2024

7. Loans to directors

Name of director receiving advance or credit: Michael Morrell
Description of the loan: Directors Loan Account
£
Balance at 01 October 2023 330,258
Advances or credits made: 41,324
Advances or credits repaid: 680
Balance at 30 September 2024 370,902
Name of director receiving advance or credit: Michael Morrell
Description of the loan: Directors Loan Account
£
Balance at 01 October 2023 330,258
Advances or credits made: 41,324
Advances or credits repaid: 680
Balance at 30 September 2024 370,902